{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T04:27:30Z","timestamp":1767068850788,"version":"3.48.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Special Project on Traditional Chinese Medicine Research in Henan Province","award":["2024ZY2171"],"award-info":[{"award-number":["2024ZY2171"]}]},{"name":"the Science and Technology Research Program of Henan Province","award":["252102310236"],"award-info":[{"award-number":["252102310236"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03544-w","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:15:23Z","timestamp":1764267323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular subtyping and a seven-gene immune signature reveal heterogeneity in tumor microenvironment and prognosis of lung adenocarcinoma"],"prefix":"10.1186","volume":"30","author":[{"given":"Hongzhi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengde","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongfeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojiu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"3","key":"3544_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3544_CR2","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429354659250320051057","author":"B Liu","year":"2025","unstructured":"Liu B, Yang C, Liu J, Peng M, Mao J, Tang S, et al. Targeting of lysosomes as a therapeutic target in cancer. Curr Mol Pharmacol. 2025. https:\/\/doi.org\/10.2174\/0118761429354659250320051057.","journal-title":"Curr Mol Pharmacol"},{"issue":"7689","key":"3544_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"key":"3544_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ebiom.2019.05.046","volume":"44","author":"D Chen","year":"2019","unstructured":"Chen D, Wang R, Yu C, Cao F, Zhang X, Yan F, et al. FOX-A1 contributes to acquisition of chemoresistance in human lung adenocarcinoma via transactivation of SOX5. EBioMedicine. 2019;44:150\u201361.","journal-title":"EBioMedicine"},{"key":"3544_CR5","doi-asserted-by":"publisher","DOI":"10.32604\/chd.2024.048081","author":"Z Song","year":"2023","unstructured":"Song Z, Yu J, Wang M, Shen W, Wang C, Lu T, et al. CHDTEPDB: transcriptome expression profile database and interactive analysis platform for congenital heart disease. Congenit Heart Dis. 2023. https:\/\/doi.org\/10.32604\/chd.2024.048081.","journal-title":"Congenit Heart Dis"},{"key":"3544_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fcell.2020.00550","volume":"8","author":"Y Song","year":"2020","unstructured":"Song Y, Yan S, Fan W, Zhang M, Liu W, Lu H, et al. Identification and validation of the immune subtypes of lung adenocarcinoma: implications for immunotherapy. Front Cell Dev Biol. 2020;8:550.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"3544_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309\u201322.","journal-title":"Cancer Cell"},{"issue":"1","key":"3544_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jhep.2019.03.018","volume":"71","author":"HJ Kang","year":"2019","unstructured":"Kang HJ, Oh JH, Chun SM, Kim D, Ryu YM, Hwang HS, et al. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes. J Hepatol. 2019;71(1):91\u2013103. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.018.","journal-title":"J Hepatol"},{"issue":"4","key":"3544_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298\u2013306.","journal-title":"Nat Rev Cancer"},{"key":"3544_CR10","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9530","volume":"8","author":"ZY Xu","year":"2020","unstructured":"Xu ZY, Zhao M, Chen W, Li K, Qin F, Xiang WW, et al. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma. PeerJ. 2020;8:e9530. https:\/\/doi.org\/10.7717\/peerj.9530.","journal-title":"PeerJ"},{"key":"3544_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.724741","volume":"12","author":"XS Liu","year":"2021","unstructured":"Liu XS, Zhou LM, Yuan LL, Gao Y, Kui XY, Liu XY, et al. NPM1 is a prognostic biomarker involved in immune infiltration of lung adenocarcinoma and associated with m6A modification and glycolysis. Front Immunol. 2021;12:724741. https:\/\/doi.org\/10.3389\/fimmu.2021.724741.","journal-title":"Front Immunol"},{"issue":"2","key":"3544_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1515\/oncologie-2023-0380","volume":"26","author":"Q Lin","year":"2024","unstructured":"Lin Q, Ma Y, Chen P. Identification of potential biomarkers in follicular thyroid carcinoma: bioinformatics and immunohistochemical analyses. Oncologie. 2024;26(2):311\u201322.","journal-title":"Oncologie"},{"key":"3544_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00424","volume":"10","author":"KW Bi","year":"2020","unstructured":"Bi KW, Wei XG, Qin XX, Li B. BTK has potential to be a prognostic factor for lung adenocarcinoma and an indicator for tumor microenvironment remodeling: a study based on TCGA data mining. Front Oncol. 2020;10:424. https:\/\/doi.org\/10.3389\/fonc.2020.00424.","journal-title":"Front Oncol"},{"issue":"12","key":"3544_CR14","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. Consensusclusterplus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btq170.","journal-title":"Bioinformatics"},{"issue":"7269","key":"3544_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, Dunn IF, et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature. 2009;462(7269):108\u201312. https:\/\/doi.org\/10.1038\/nature08460.","journal-title":"Nature"},{"key":"3544_CR16","doi-asserted-by":"crossref","unstructured":"Jiang T, Zheng J, Li N, Li X, He J, Zhou J, Sun B, Chi Q. Dissecting the mechanisms of intestinal immune homeostasis by analyzing T-cell immune response in Crohn's disease and colorectal cancer. Current Gene Therapy. 2024;24(5):422\u201340.","DOI":"10.2174\/0115665232294568240201073417"},{"issue":"7","key":"3544_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"3544_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"key":"3544_CR19","doi-asserted-by":"crossref","unstructured":"Zhang L, Yang H, Liu J, Wang K, Cai X, Xiao W, Wang L, Wang M, Zhang C, Zhang J. Metabolomics-based approach to analyze the therapeutic targets and metabolites of a synovitis ointment for knee osteoarthritis. Curr Pharmaceutical Anal. 2023;19(3):222\u201334.","DOI":"10.2174\/1573412919666221223152915"},{"issue":"49","key":"3544_CR20","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.1038\/s41388-021-02044-5","volume":"40","author":"SK Liang","year":"2021","unstructured":"Liang SK, Hsu CC, Song HL, Huang YC, Kuo CW, Yao X, et al. Correction: FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis. Oncogene. 2021;40(49):6705.","journal-title":"Oncogene"},{"issue":"4","key":"3544_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008692","volume":"16","author":"C Goda","year":"2020","unstructured":"Goda C, Balli D, Black M, Milewski D, Le T, Ustiyan V, et al. Loss of FOXM1 in macrophages promotes pulmonary fibrosis by activating p38 MAPK signaling pathway. PLoS Genet. 2020;16(4):e1008692.","journal-title":"PLoS Genet"},{"issue":"26","key":"3544_CR22","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1038\/s41388-021-01853-y","volume":"40","author":"J Wu","year":"2021","unstructured":"Wu J, Li L, Zhang H, Zhao Y, Zhang H, Wu S, et al. A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma. Oncogene. 2021;40(26):4413\u201324.","journal-title":"Oncogene"},{"issue":"4","key":"3544_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034943","volume":"7","author":"CM Wright","year":"2012","unstructured":"Wright CM, Savarimuthu Francis SM, Tan ME, Martins MU, Winterford C, Davidson MR, et al. MS4A1 dysregulation in asbestos-related lung squamous cell carcinoma is due to CD20 stromal lymphocyte expression. PLoS ONE. 2012;7(4):e34943.","journal-title":"PLoS ONE"},{"issue":"1","key":"3544_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12285-8","volume":"24","author":"L Xia","year":"2024","unstructured":"Xia L, Lin H, Cao H, Lian J. Tenascin C as a novel zinc finger protein 750 target regulating the immunogenicity via DNA damage in lung squamous cell carcinoma. BMC Cancer. 2024;24(1):561.","journal-title":"BMC Cancer"},{"key":"3544_CR25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.2147\/OTT.S286274","volume":"14","author":"CS Zhou","year":"2021","unstructured":"Zhou CS, Feng MT, Chen X, Gao Y, Chen L, Li LD, et al. Exonuclease 1 (EXO1) is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. Onco Targets Ther. 2021;14:1033\u201348.","journal-title":"Onco Targets Ther"},{"issue":"14","key":"3544_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.14715\/cmb\/2023.69.14.9","volume":"69","author":"Y Luo","year":"2023","unstructured":"Luo Y, Zhang S, Xie H, Su Q, He S, Lei Z. Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma. Cell Mol Biol (Noisy-le-grand). 2023;69(14):51\u201361.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"6","key":"3544_CR27","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2020.02.146","volume":"8","author":"G Wu","year":"2020","unstructured":"Wu G, Zhao Z, Yan Y, Zhou Y, Wei J, Chen X, et al. CPS1 expression and its prognostic significance in lung adenocarcinoma. Ann Transl Med. 2020;8(6):341.","journal-title":"Ann Transl Med"},{"issue":"30","key":"3544_CR28","doi-asserted-by":"publisher","first-page":"29585","DOI":"10.18632\/oncotarget.4987","volume":"6","author":"YL Hsu","year":"2015","unstructured":"Hsu YL, Hung JY, Liang YY, Lin YS, Tsai MJ, Chou SH, et al. S100P interacts with integrin alpha7 and increases cancer cell migration and invasion in lung cancer. Oncotarget. 2015;6(30):29585\u201398.","journal-title":"Oncotarget"},{"issue":"4","key":"3544_CR29","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.18632\/aging.102861","volume":"12","author":"L Dong","year":"2020","unstructured":"Dong L, Zheng J, Gao Y, Zhou X, Song W, Huang J. The circular RNA NT5E promotes non-small cell lung cancer cell growth via sponging microRNA-134. Aging (Albany NY). 2020;12(4):3936\u201349.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"3544_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3233\/CBM-201045","volume":"31","author":"P Xu","year":"2021","unstructured":"Xu P, Mo X, Xia R, Jiang L, Zhang C, Xu H, et al. KCNN4 promotes the progression of lung adenocarcinoma by activating the AKT and ERK signaling pathways. Cancer Biomark. 2021;31(2):187\u2013201.","journal-title":"Cancer Biomark"},{"key":"3544_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137353","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Richmond A, Yan C. Immunomodulatory properties of PI3K\/AKT\/mTOR and MAPK\/MEK\/ERK inhibition augment response to immune checkpoint blockade in melanoma and triple-negative breast cancer. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23137353.","journal-title":"Int J Mol Sci"},{"key":"3544_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701006","volume":"12","author":"WT Zhou","year":"2021","unstructured":"Zhou WT, Jin WL. B7-H3\/CD276: an emerging cancer immunotherapy. Front Immunol. 2021;12:701006. https:\/\/doi.org\/10.3389\/fimmu.2021.701006.","journal-title":"Front Immunol"},{"issue":"9","key":"3544_CR33","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.stem.2021.04.011","volume":"28","author":"C Wang","year":"2021","unstructured":"Wang C, Li Y, Jia L, Kim JK, Li J, Deng P, et al. CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance. Cell Stem Cell. 2021;28(9):1597-1613 e1597.","journal-title":"Cell Stem Cell"},{"key":"3544_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.canlet.2020.10.032","volume":"497","author":"Y Li","year":"2021","unstructured":"Li Y, Chen Y, Miao L, Wang Y, Yu M, Yan X, et al. Stress-induced upregulation of TNFSF4 in cancer-associated fibroblast facilitates chemoresistance of lung adenocarcinoma through inhibiting apoptosis of tumor cells. Cancer Lett. 2021;497:212\u201320.","journal-title":"Cancer Lett"},{"issue":"9","key":"3544_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"SC Sun","year":"2017","unstructured":"Sun SC. The non-canonical NF-kappaB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17(9):545\u201358.","journal-title":"Nat Rev Immunol"},{"key":"3544_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108429","volume":"102","author":"J Wu","year":"2022","unstructured":"Wu J, Wang Y, Yang Y, Liu F, Jiang Z, Jiang Z. TNFSF9 promotes metastasis of pancreatic cancer by regulating M2 polarization of macrophages through Src\/FAK\/p-Akt\/IL-1beta signaling. Int Immunopharmacol. 2022;102:108429.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"3544_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12029-020-00371-6","volume":"52","author":"J Wu","year":"2021","unstructured":"Wu J, Wang Y, Jiang Z. TNFSF9 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. J Gastrointest Cancer. 2021;52(1):150\u20139.","journal-title":"J Gastrointest Cancer"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03544-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03544-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T04:24:41Z","timestamp":1767068681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03544-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3544"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03544-w","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1301"}}